AtriCure Inc reports results for the quarter ended June 30 - Earnings Summary

AtriCure

23/07/2026 22:03

AtriCure Inc ATRC.OQ reported quarterly adjusted earnings of 18 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -2 cents.  The mean expectation of nine analysts for the quarter was for breakeven results per share. Wall Street expected results to range from -6 cents to 9 cents per share.
Revenue rose 12.8% to $153.60 million from a year ago; analysts expected $151.84 million. 
AtriCure Inc's reported EPS for the quarter was 18 cents​.
The company reported quarterly net income of $8.96 million.
AtriCure Inc shares had risen by 19.8% this quarter and lost 15.3% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 80% in the last three months.​ 
In the last 30 days, one analyst negatively revised an earnings estimate
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 8 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is also "buy" 
Wall Street's median 12-month price target for AtriCure Inc is $50.00, about 33% above its last closing price of $33.52
This summary was machine generated from LSEG data July 23 at 09:03 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
0.00
0.18
Beat
Mar. 31 2026 
-0.06
0.00
Beat
Dec. 31 2025 
-0.09
0.04
Beat
Sep. 30 2025 
-0.11
-0.01
Beat